Biologic drug developments markets such as monoclonal antibodies, biosimilars, gene therapy, are highly growing while all developers need to decrease their cost of goods and reach
market as quick as possible.
At AmplyCell we have developed the AMPLY™ Technology that makes it possible to produce biomolecules and drugs at affordable cost. We directly adress the holy cow of BioPharma industry, their cell lines used for their bioproduction, making them up to 10x more profitable in terms of yield and even more in term of financial profit.
AMPLY™Technology is based on physical stimulation treatments that activate cell line metabolism and productivity in a permanent way. By applying on cell lines such as Chinese Hamster Ovary (CHO), Human Embryonic Kidney (HEK293) and hybridomas, it allows cost-effective and efficient GMP manufacturing of recombinant proteins, difficult-to-express New Biological Entities, Biosimilars drugs and viral vectors.